Recent publications on Biostatistics
Cook AJ, Gold DR, Li Y. Spatial cluster detection for longitudinal outcomes using administrative regions. Commun Stat Theory Methods. 2013;42(12):2105-17. PubMed
Hubbard RA, Miglioretti DL. A semiparametric censoring bias model for estimating the cumulative risk of a false-positive screening test under dependent censoring. Biometrics. 2013 Mar;69(1):245-53. doi: 10.1111/j.1541-0420.2012.01831.x. Epub 2013 Feb 5. PubMed
Zhang S, Barros SP, Moretti AJ, Yu N, Zhou J, Preisser JS, Niculescu MD, Offenbacher S. Epigenetic regulation of TNFA xpression in periodontal disease. J Periodontol. 2013 Nov;84(11):1606-16. doi: 10.1902/jop.2013.120294. Epub 2013 Jan 31. PubMed
Shan L, Chen YA, Davis L, Han G, Zhu W, Molina AD, Arango H, LaPolla JP, Hoffman MS, Sellers T, Kirby T, Nicosia SV, Sutphen R. Measurement of phospholipids improve diagnostic accuracy in ovarian cancer. PLoS One. 2012;7(10):e46846. doi: 10.1371/journal.pone.0046846. Epub 2012 Oct 17. PubMed
Su YR, Wang JL. Modeling left-truncated and right-censored survival data with longitudinal covariates. Ann Stat. 2012 Jun;40(3):1465-1488. doi: 10.1214/12-AOS996. Epub 2012 Sep 5. PubMed
Xu S, Zeng C, Newcomer S, Nelson JC, Glanz J. Use of fixed effects models to analyze self-controlled case series data in vaccine safety studies. J Biom Biostat. 2012 Apr 19;Suppl 7:006. PubMed
Mahajan K, Coppola D, Chen YA, Zhu W, Lawrence HR, Lawrence NJ, Mahajan NP. Ack1 tyrosine kinase activation correlates with pancreatic cancer progression. Am J Pathol. 2012 Apr;180(4):1386-93. doi: 10.1016/j.ajpath.2011.12.028. Epub 2012 Feb 7. PubMed
Cook AJ, Tiwari RC, Wellman RD, Heckbert SR, Li L, Heagerty P, Marsh T, Nelson JC. Statistical approaches to group sequential monitoring of postmarket safety surveillance data: current state of the art for use in the Mini-Sentinel pilot. Pharmacoepidemiol Drug Saf. 2012;21 Suppl 1:72-81. doi: 10.1002/pds.2320. PubMed
Finkelstein S, Trotti A, Rao N, Reintgen D, Cruse W, Feun L, Sondak V, Yu D, Zhu W, Gwede C, DeConti R. The Florida Melanoma Trial I: a prospective multicenter phase I/II trial of postoperative hypofractionated adjuvant radiotherapy with concurrent interferon-alfa-2b in the treatment of advanced stage III melanoma with long-term toxicity follow-up. ISRN Immunology. 2012;2012:[10 p.]. doi:10.5402/2012/324235. PubMed
Wong ES, Wang BC, Garrison LP, Alfonso-Cristancho R, Flum DR, Arterburn DE, Sullivan SD. Examining the BMI-mortality relationship using fractional polynomials. BMC Med Res Methodol. 2011 Dec 28;11(1):175. PubMed


